Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 27% ± 7% | |
glutamatergic neuron | 3 studies | 35% ± 13% |
Insufficient scRNA-seq data for expression of IL34 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 99% | 1783.41 | 255 / 258 | 90% | 31.86 | 206 / 230 |
brain | 72% | 764.18 | 1911 / 2642 | 85% | 11.12 | 602 / 705 |
thymus | 56% | 386.22 | 363 / 653 | 98% | 18.05 | 591 / 605 |
prostate | 59% | 464.08 | 144 / 245 | 86% | 6.80 | 434 / 502 |
breast | 64% | 803.29 | 292 / 459 | 79% | 15.28 | 879 / 1118 |
skin | 72% | 3492.44 | 1300 / 1809 | 62% | 10.50 | 294 / 472 |
kidney | 37% | 290.70 | 33 / 89 | 83% | 11.88 | 749 / 901 |
lung | 48% | 332.45 | 275 / 578 | 70% | 7.10 | 810 / 1155 |
esophagus | 60% | 862.06 | 862 / 1445 | 56% | 4.84 | 102 / 183 |
intestine | 36% | 275.73 | 347 / 966 | 71% | 6.54 | 375 / 527 |
uterus | 34% | 257.47 | 57 / 170 | 69% | 10.96 | 319 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.89 | 29 / 29 |
spleen | 100% | 8920.39 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.73 | 1 / 1 |
pancreas | 1% | 6.29 | 4 / 328 | 90% | 9.29 | 161 / 178 |
stomach | 11% | 76.09 | 40 / 359 | 78% | 7.76 | 222 / 286 |
tonsil | 0% | 0 | 0 / 0 | 84% | 15.48 | 38 / 45 |
bladder | 24% | 237.76 | 5 / 21 | 59% | 6.07 | 298 / 504 |
ovary | 3% | 22.94 | 6 / 180 | 70% | 7.40 | 302 / 430 |
blood vessel | 73% | 1114.32 | 969 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 4.25 | 50 / 80 |
liver | 3% | 14.69 | 6 / 226 | 58% | 6.79 | 236 / 406 |
adipose | 36% | 285.37 | 437 / 1204 | 0% | 0 | 0 / 0 |
muscle | 30% | 340.16 | 239 / 803 | 0% | 0 | 0 / 0 |
heart | 10% | 56.75 | 89 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0120041 | Biological process | positive regulation of macrophage proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0045651 | Biological process | positive regulation of macrophage differentiation |
GO_0061518 | Biological process | microglial cell proliferation |
GO_0061514 | Biological process | interleukin-34-mediated signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0045657 | Biological process | positive regulation of monocyte differentiation |
GO_0010759 | Biological process | positive regulation of macrophage chemotaxis |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061098 | Biological process | positive regulation of protein tyrosine kinase activity |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005157 | Molecular function | macrophage colony-stimulating factor receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005125 | Molecular function | cytokine activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IL34 |
Protein name | Interleukin-34 (IL-34) Interleukin 34 |
Synonyms | C16orf77 |
Description | FUNCTION: Cytokine that promotes the proliferation, survival and differentiation of monocytes and macrophages. Promotes the release of pro-inflammatory chemokines, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, and in the regulation of bone resorption. Signaling via CSF1R and its downstream effectors stimulates phosphorylation of MAPK1/ERK2 AND MAPK3/ERK1. . |
Accessions | ENST00000429149.6 [Q6ZMJ4-1] ENST00000288098.7 [Q6ZMJ4-1] J3QQT3 ENST00000566361.1 Q6ZMJ4 |